Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proteasome 26S subunit, ATPase 1 pseudogene 9 (PSMC1P9)
- Target
- PSMC1P9
- Molecular classification
- Pseudogene, Not a protein-coding gene
01
Overview
PSMC1P9 is classified as a pseudogene corresponding to the ATPase 1 subunit of the 26S proteasome. Pseudogenes are genomic DNA sequences similar to normal genes but are generally non-functional due to mutations or lack of regulatory elements necessary for expression. PSMC1P9 does not encode a protein product and is not known to produce a functional RNA with regulatory properties. Therefore, it is not considered a therapeutic target, does not interact with drugs, is not used as a biomarker, and does not have an established role in disease. The functional, protein-coding counterpart is the PSMC1 gene, which encodes one of the six AAA-ATPase subunits that form the base of the 19S regulatory particle of the 26S proteasome complex. However, PSMC1P9 itself is not an active subunit of the proteasome. PSMC1P9 lacks evidence as a therapeutic target, is not protein coding, and does not play a direct role in cellular processes.
- Other names
- Proteasome (prosome, macropain) 26S subunit, ATPase, 1 pseudogene 9PSMC1P9
02
Mechanism of action
None
03
Biological functions
None (pseudogenes do not code for functional proteins and generally, do not have known direct biological functions; some pseudogenes may have regulatory roles, but none are described for PSMC1P9)
04
Disease associations
No established disease association (as typical for pseudogenes, unless regulatory functions are specifically reported, which is not the case here)
Beyond the preview
Go deeper on Proteasome 26S subunit, ATPase 1 pseudogene 9 (PSMC1P9).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Proteasome 26S subunit, ATPase 1 pseudogene 9 (PSMC1P9).